These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 28404651)

  • 21. Primary drug resistance among pulmonary treatment-naïve tuberculosis patients in Amazonas State, Brazil.
    da Silva Garrido M; Ramasawmy R; Perez-Porcuna TM; Zaranza E; Chrusciak Talhari A; Martinez-Espinosa FE; Bührer-Sékula S
    Int J Tuberc Lung Dis; 2014 May; 18(5):559-63. PubMed ID: 24903793
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tuberculosis Treatment Outcome and Drug Resistance in Lambaréné, Gabon: A Prospective Cohort Study.
    Bélard S; Remppis J; Bootsma S; Janssen S; Kombila DU; Beyeme JO; Rossatanga EG; Kokou C; Osbak KK; Obiang Mba RM; Kaba HM; Traoré AN; Ehrhardt J; Bache EB; Flamen A; Rüsch-Gerdes S; Frank M; Adegnika AA; Lell B; Niemann S; Kremsner PG; Loembé MM; Alabi AS; Grobusch MP
    Am J Trop Med Hyg; 2016 Aug; 95(2):472-80. PubMed ID: 27352879
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Totally drug-resistant and extremely drug-resistant tuberculosis: the same disease?
    Migliori GB; Centis R; D'Ambrosio L; Spanevello A; Borroni E; Cirillo DM; Sotgiu G
    Clin Infect Dis; 2012 May; 54(9):1379-80. PubMed ID: 22492321
    [No Abstract]   [Full Text] [Related]  

  • 24. Trench warfare in a battle with TB.
    Marshall E
    Science; 2008 Jul; 321(5887):362-4. PubMed ID: 18635790
    [No Abstract]   [Full Text] [Related]  

  • 25. [Resistance to first-line drugs and major genotypic lineages of Mycobacterium tuberculosis in the 3 French Department of the Americas: Profiles, evolution, and trends (1995-2011)].
    Millet J; Berchel M; Prudenté F; Streit E; Bomer AG; Schuster F; Vanhomwegen J; Paasch D; Galbert I; Valery E; Aga R; Rastogi N
    Bull Soc Pathol Exot; 2014 May; 107(2):90-105. PubMed ID: 24627041
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Co-infection with Drug-Susceptible and Reactivated Latent Multidrug-Resistant Mycobacterium tuberculosis.
    Pérez-Lago L; Lirola MM; Navarro Y; Herranz M; Ruiz-Serrano MJ; Bouza E; García-de-Viedma D
    Emerg Infect Dis; 2015 Nov; 21(11):2098-100. PubMed ID: 26488258
    [No Abstract]   [Full Text] [Related]  

  • 27. Emerging resistant clone of Mycobacterium tuberculosis in west Asia.
    Mokrousov I
    Lancet Infect Dis; 2016 Dec; 16(12):1326-1327. PubMed ID: 27998587
    [No Abstract]   [Full Text] [Related]  

  • 28. Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis.
    Becerra MC; Freeman J; Bayona J; Shin SS; Kim JY; Furin JJ; Werner B; Sloutsky A; Timperi R; Wilson ME; Pagano M; Farmer PE
    Int J Tuberc Lung Dis; 2000 Feb; 4(2):108-14. PubMed ID: 10694087
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Faster for less: the new "shorter" regimen for multidrug-resistant tuberculosis.
    Sotgiu G; Tiberi S; D'Ambrosio L; Centis R; Alffenaar JW; Caminero JA; Abdo Arbex M; Alarcon Guizado V; Aleksa A; Dore S; Gaga M; Gualano G; Kunst H; Payen MC; Roby Arias AJ; Skrahina A; Solovic I; Sulis G; Tadolini M; Zumla A; Migliori GB;
    Eur Respir J; 2016 Nov; 48(5):1503-1507. PubMed ID: 27587544
    [No Abstract]   [Full Text] [Related]  

  • 30. Increasing drug resistance of Mycobacterium tuberculosis in Sinaloa, Mexico, 1997-2005.
    Zazueta-Beltran J; León-Sicairos N; Muro-Amador S; Flores-Gaxiola A; Velazquez-Roman J; Flores-Villaseñor H; Canizalez-Roman A
    Int J Infect Dis; 2011 Apr; 15(4):e272-6. PubMed ID: 21317004
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extensively drug-resistant tuberculosis: new strains, new challenges.
    Banerjee R; Schecter GF; Flood J; Porco TC
    Expert Rev Anti Infect Ther; 2008 Oct; 6(5):713-24. PubMed ID: 18847407
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thyroid function in multidrug-resistant tuberculosis patients with or without human immunodeficiency virus (HIV) infection before commencement of MDR-TB drug regimen.
    Ige OM; Akinlade KS; Rahamon SK; Edem VF; Arinola OG
    Afr Health Sci; 2016 Jun; 16(2):596-602. PubMed ID: 27605977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extensively drug-resistant tuberculosis is worse than multidrug-resistant tuberculosis: different methodology and settings, same results.
    Migliori GB; Lange C; Girardi E; Centis R; Besozzi G; Kliiman K; Ortmann J; Matteelli A; Spanevello A; Cirillo DM;
    Clin Infect Dis; 2008 Mar; 46(6):958-9. PubMed ID: 18288911
    [No Abstract]   [Full Text] [Related]  

  • 34. Mycobacterium tuberculosis drug-resistance in previously treated patients in Ouagadougou, Burkina Faso.
    Sangare L; Diande S; Kouanda S; Dingtoumda BI; Mourfou A; Ouedraogo F; Sawadogo I; Nebie B; Gueye A; Sawadogo LT; Traore AS
    Ann Afr Med; 2010; 9(1):15-9. PubMed ID: 20418644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multi-drug resistant tuberculosis in Northern Pakistan.
    Butt T; Ahmad RN; Kazmi SY; Rafi N
    J Pak Med Assoc; 2004 Sep; 54(9):469-72. PubMed ID: 15518370
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pre-XDR & XDR in MDR and Ofloxacin and Kanamycin resistance in non-MDR Mycobacterium tuberculosis isolates.
    Jain A; Dixit P; Prasad R
    Tuberculosis (Edinb); 2012 Sep; 92(5):404-6. PubMed ID: 22789499
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of lipid metabolism-targeting compounds active against drug-resistant M. tuberculosis.
    Singh AK; Karaulia P; Yadav P; Narender T; Singh SP; Sashidhara KV; Pandey AK; Chopra S; Dasgupta A
    J Glob Antimicrob Resist; 2016 Dec; 7():26-27. PubMed ID: 27552738
    [No Abstract]   [Full Text] [Related]  

  • 38. [Multicenter transversal study of tuberculosis and drug resistance in Madrid (October 1993-April 1994)].
    Med Clin (Barc); 1996 Jan; 106(1):1-6. PubMed ID: 8750533
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Additional Drug Resistance Patterns among Multidrug-Resistant Tuberculosis Patients in Korea: Implications for Regimen Design.
    Mok JH; Kang BH; Lee T; Lee HK; Jang HJ; Cho YJ; Jeon D
    J Korean Med Sci; 2017 Apr; 32(4):636-641. PubMed ID: 28244290
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comment on "Thwaites et al., 2005, The influence of HIV infection on clinical presentation, response to treatment, and outcome in adults with Tuberculous meningitis" J Infect Dis. 2005 Dec 15;192(12):2134-41.
    Dhasmana DJ; Davidson RN
    J Infect; 2007 Feb; 54(2):205; author reply 206. PubMed ID: 16887190
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.